ARCHIVES

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

This article is from The Cancer Letter archive.

Vol. 16 No. 17 | April 27, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010